Top melanoma-treatment Providers in abingdon

Stratum Dermatology Clinic Oxford

Profile
Stratum Dermatology Clinic Oxford

Dermatologist

Rating
(43 reviews)
Location
Abingdon OX13 6FD, United Kingdom
Treatments offered

Melanoma-treatment Treatment in Abingdon

Melanoma treatment means the set of medical ways doctors try to remove or control melanoma, which is a type of skin cancer. In the UK and elsewhere, the foundation is surgery to cut out the tumour and some normal skin around it so theres less chance of cells being left behind. Depending on stage and spread, they might add radiotherapy, targeted cancer drugs that block specific proteins in cancer cells, or immunotherapy which helps your own immune system recognise and attack the melanoma cells. Chemotherapy is still used sometimes, but in melanoma its usually less effective than modern immunotherapy or targeted drugs. The exact mix depends on stage, genetics of the tumour (like whether theres a BRAF mutation), and your overall health.
Our dataset currently has 1 clinic(s), with approximately 43 reviews and an average rating of 4.5.

Medical Infrastructure:

    • Community hospital presence (Abingdon Community Hospital)
    • Close proximity to John Radcliffe Hospital (Oxford) and Oxford University Hospitals NHS Foundation Trust
    • Established GP network

Local Aethetics Market:

    Mature medical dermatology market supported by affluent commuter demographic

Goals of Melanoma-treatment Treatment

  • Remove the primary melanoma completely so it doesnt come back locally.
  • Reduce risk of spread to lymph nodes or other organs.
  • Control melanoma that has already spread to prolong life and manage symptoms.
  • Use systemic treatments like immunotherapy to train the immune system to attack melanoma cells.
  • Tailor the plan to your overall health and minimise side effects through multidisciplinary discussion.

Melanoma-treatment Treatment Options

Medical & Non-Surgical Approaches

  • Surgery is the mainstay for early melanoma; non-surgical alternatives like imiquimod cream may be used for very early or superficial disease in selected cases.
  • Radiotherapy is sometimes added for local control where surgery isnt option.
  • Systemic options like immunotherapy or targeted drugs arent alternative in the usual sense but are evidence-based treatments for spread or high-risk disease; they work differently from surgery by acting systemically.
  • There isnt high-quality evidence for complementary therapies curing melanoma; they may be supportive for wellbeing but not a substitute for evidence-based care.

Pros of Melanoma-treatment Treatment

  • Early stage surgery can be curative and very effective.
  • Modern immunotherapies have improved outcomes for advanced melanoma.
  • Targeted drugs can slow or halt cancer growth by focusing on specific tumour pathways.
  • Follow-up and surveillance help catch recurrence early.

Cons of Melanoma-treatment Treatment

  • Side effects from immunotherapy or targeted drugs can be serious and long-lasting.
  • Advanced melanoma treatment isnt guaranteed and sometimes slows rather than cures.
  • Radiotherapy and chemotherapy can cause fatigue, nausea and other systemic effects.
  • Theres emotional and physical burden to undergoing cancer treatment.

Cost of Melanoma-treatment Treatment in Abingdon

  • Costs vary massively by stage and what treatments are used. On the NHS most standard treatments are funded so you dont pay directly, but analyses show average cumulative costs per patient in 2023 in the UK were roughly GBP 9,500 for early Stage I, GBP 77,800 for Stage II, GBP 179,300 for Stage III and GBP 213,800 for Stage IV melanoma. This includes surgeries, medicines, scans and follow-ups over time.
  • If someone chooses private care or private medicines not fully funded on the NHS, very rough figures for immunotherapy courses in the UK can range widely (e.g. around GBP 25,000 to over GBP 100,000 depending on drugs and cycles), though specifics depend on exact regimen and hospital.
  • Stage at diagnosis (early is much cheaper than advanced).
  • Choice of therapy (immunotherapy, targeted drugs, complex surgery).
  • Private versus NHS care and whether your insurer covers medicines.
  • Geography and clinic overheads.

Accessibility

Public transport:

    • Bus links to Oxford
    • Nearby Radley and Didcot Parkway rail stations providing national rail connectivity

Parking availability:

    Generally good parking availability compared to Oxford city centre

Clinic distribution:

    Likely located within town centre or medical practice cluster area

Airport proximity:

    Heathrow Airport approximately 1–1.5 hours by road

Preparing for Your Melanoma-treatment Appointment

  • Talk openly with your specialist about expectations, side effects, and timing.
  • Ask about scans and tests before treatment starts to get accurate staging.
  • Discuss fertility or pregnancy plans if relevant, as some treatments can affect these.
  • Get baseline blood tests, organ checks and support networks in place.
Systemic therapies are given in schedules (e.g immunotherapy every few weeks for up to a year or longer based on response).

Treatment Safety & Local Regulations

Surgery carries usual risks like infection, bleeding and scarring.Immunotherapy can cause immune-related side effects affecting skin, gut, liver, thyroid and more.Targeted drugs have side effects like fever, rash or fatigue.

Pain varies by treatment type. Surgery is done with anaesthesia so you feel little during it but some after. Systemic therapies arent usually painful physically but can make you feel unwell.

  • If they do surgical melanoma treatment theyll be a surgical oncologist or dermatologist trained in skin cancer surgery.
  • Systemic therapy is managed by medical oncologists experienced in melanoma.
  • All teams work within NHS or accredited private hospital governance and have specialist nursing support.
Yes, NICE has detailed guidance on melanoma assessment and management covering staging, surgery, adjuvant therapy, systemic treatment choices, follow-up and multidisciplinary care. Drugs used are regulated by MHRA in the UK and globally similar protocols are referenced by FDA and other bodies.

Local regulatory authority:

    • Care Quality Commission (CQC) for independent healthcare services in England
    • General Medical Council (GMC) for dermatologist registration

Private insurance usage locally:

    Moderate-to-high for dermatology consultations and skin cancer procedures (Bupa, AXA, WPA commonly accepted in region)

Cosmetic finance availability:

    • Less common for core dermatology
    • Aesthetic add-ons may be self-funded

Who Is a Good Candidate?

  • Anyone diagnosed with melanoma, because treatment is tailored to stage and risk.
  • People with early melanoma usually have surgery with high chance of cure.
  • Those with stage III or IV disease or high risk may get immunotherapy or targeted therapy.
  • Its less about being a candidate and more about staging and shared decision-making with your oncology team.

Choosing a Clinic

  • If they do surgical melanoma treatment theyll be a surgical oncologist or dermatologist trained in skin cancer surgery.
  • Systemic therapy is managed by medical oncologists experienced in melanoma.
  • All teams work within NHS or accredited private hospital governance and have specialist nursing support.
  • A multidisciplinary team experienced in skin cancer, including surgical oncologists, dermatologists, medical oncologists and specialist nurses.
  • Clear communication about options, risks, prognosis and follow-up.
  • Access to genetic testing of the tumour (like BRAF status) to personalise systemic therapy.
  • Transparent discussion of whether any proposed therapy is on the NHS or why a private option is recommended.
  • Support services for emotional and practical care.
Current average rating citywide: 4.5

Recovery & Long-Term Results

  • After surgery you may need days to weeks to heal depending on area and extent. Systemic therapies have ongoing effects and require monitoring.
  • Surgical wound pain and scarring.
  • Fatigue, skin rash, diarrhea, hormone changes from immunotherapy.
  • Targeted drug related symptoms like fever or joint pain.
Aftercare:
  • Surgery is the mainstay for early melanoma; non-surgical alternatives like imiquimod cream may be used for very early or superficial disease in selected cases.
  • Radiotherapy is sometimes added for local control where surgery isnt option.
  • Systemic options like immunotherapy or targeted drugs arent alternative in the usual sense but are evidence-based treatments for spread or high-risk disease; they work differently from surgery by acting systemically.
  • There isnt high-quality evidence for complementary therapies curing melanoma; they may be supportive for wellbeing but not a substitute for evidence-based care.